Figure 1.

- Association of rs145204276 polymorphism with OSI markers and liver injury markers in sevoflurane group and propofol group. (A-C) Comparing the serum (A) MDA, (B) IL-6 and (C) TNF-α levels between Del-sevoflurane subgroup and Del-propofol subgroup in TM1, TM2 and TM3. (D-E) Comparing the serum (D) AST, and (E) ALT levels between Del-Sevoflurane subgroup and Del-propofol subgroup in TM1, TM4 and TM5. (F-H) Comparing the the serum (F) MDA, (G) IL-6, and (H) TNF-α levels between Ins-sevoflurane subgroup and Ins-propofol subgroup in TM1, TM2 and TM3. (I-J) Comparing the serum (I) AST, and (J) ALT levels between Ins-sevoflurane subgroup and Ins-propofol subgroup in TM1, TM4 and TM5. IL-6 and TNF-α were expressed by fold change compared with TM1 baselines. OSI: oxidative stress injury